CNBX Pharmaceuticals Inc. (CNBX) stock
CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $197.79KP/E –Yield –
CNBX Pharmaceuticals gross margin
Gross margin is gross profit as a percentage of revenue.
CNBX Pharmaceuticals's gross margin for the twelve months ending Feb 28, 2018 was 100.0%. For fiscal 2017 it was 100.0%, against 100.0% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2017 | Aug 31, 2017 | 100.0% | +0.0 |
| FY2016 | Aug 31, 2016 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024CQ1 2024 | Feb 29, 2024 | 84.7% | −15.3 |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | 100.0% | +0.0 |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | 100.0% | +0.0 |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | 100.0% | +0.0 |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | 100.0% | – |
| Q3 FY2017CQ2 2017 | May 31, 2017 | 100.0% | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | 100.0% | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | 100.0% | – |
See a number that looks wrong?